Sign Up to like & get
recommendations!
2
Published in 2023 at "Drug Design, Development and Therapy"
DOI: 10.2147/dddt.s401969
Abstract: Background Remimazolam tosilate (RT) is a new ultrashort-acting γ-aminobutyric acid subtype A (GABAA) agonist, with the characteristics of rapid onset and offset, minimal cardiorespiratory depression. Currently, few studies have compared the effect of RT and…
read more here.
Keywords:
hemodynamics;
group group;
group;
etomidate hemodynamics ... See more keywords